Prevalence, Profile, and Prognosis of Severe Obesity in Contemporary Hospitalized Heart Failure Trial Populations

JACC: Heart Failure

Volumn 4, Issue 12, 2016, Pages 923-931

  Joyce, Emer ^a   Lala, Anuradha ^b   Stevens, Susanna R ^c   Cooper, Lauren B ^c,d   AbouEzzeddine, Omar F ^e   Groarke, John D ^f   Grodin, Justin L ^a   Braunwald, Eugene ^f   Anstrom, Kevin J ^c   Redfield, Margaret M ^e   Stevenson, Lynne W ^f  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e MAYO CLINIC   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

acute decompensated heart failure; obesity; prognosis; severe obesity

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; TROPONIN I; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ACUTE HEART FAILURE; ADULT; AGE; AGED; ARTICLE; BODY MASS; CLINICAL RESEARCH; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENDER; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; HYPERTENSION; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; WORLD HEALTH ORGANIZATION; AGE DISTRIBUTION; BLOOD; DOUBLE BLIND PROCEDURE; HEART FAILURE; HEART STROKE VOLUME; HOSPITALIZATION; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; SEX RATIO; UNITED STATES; VERY ELDERLY;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BODY MASS INDEX; DIABETES MELLITUS; DOUBLE-BLIND METHOD; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; OBESITY; OBESITY, MORBID; OVERWEIGHT; PEPTIDE FRAGMENTS; PREVALENCE; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; STROKE VOLUME; TROPONIN I; UNITED STATES;

EID: 84999218646     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2016.09.013     Document Type: Article

References (28)

1. 1 Flegal, K.M., Carroll, M.D., Ogden, C.L., Johnson, C.L., Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288 (2002), 1723–1727.
2. 2 Mozaffarian, D., Benjamin, E.J., Go, A.S., et al. Heart disease and stroke statistics–2016 update: a report from the American Heart Association. Circulation 133 (2016), e38–e360.
3. 3 Ogden, C.L., Carroll, M.D., Kit, B.K., Flegal, K.M., Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA 311 (2014), 806–814.
4. 4 Lavie, C.J., Milani, R.V., Ventura, H.O., Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 53 (2009), 1925–1932.
5. 5 Flegal, K.M., Kruszon-Moran, D., Carroll, M.D., Fryar, C.D., Ogden, C.L., Trends in obesity among adults in the United States, 2005 to 2014. JAMA 315 (2016), 2284–2291.
6. 6 Abel, E.D., Litwin, S.E., Sweeney, G., Cardiac remodeling in obesity. Physiol Rev 88 (2008), 389–419.
7. 7 Alpert, M.A., Terry, B.E., Mulekar, M., et al. Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss. Am J Cardiol 80 (1997), 736–740.
8. 8 Horwich, T.B., Fonarow, G.C., Hamilton, M.A., MacLellan, W.R., Woo, M.A., Tillisch, J.H., The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 38 (2001), 789–795.
9. 9 Fonarow, G.C., Srikanthan, P., Costanzo, M.R., et al. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J 153 (2007), 74–81.
10. 10 Shah, R., Gayat, E., Januzzi, J.L. Jr., et al. Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox. J Am Coll Cardiol 63 (2014), 778–785.
11. 11 Lavie, C.J., Alpert, M.A., Arena, R., Mehra, M.R., Milani, R.V., Ventura, H.O., Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. J Am Col Cardiol HF 1 (2013), 93–102.
12. 12 Das, S.R., Alexander, K.P., Chen, A.Y., et al. Impact of body weight and extreme obesity on the presentation, treatment, and in-hospital outcomes of 50,149 patients with ST-segment elevation myocardial infarction results from the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol 58 (2011), 2642–2650.
13. 13 Angeras, O., Albertsson, P., Karason, K., et al. Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish Coronary Angiography and Angioplasty Registry. Eur Heart J 34 (2013), 345–353.
14. 14 Sharma, A., Lavie, C.J., Borer, J.S., et al. Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure. Am J Cardiol 115 (2015), 1428–1434.
15. 15 Felker, G.M., Lee, K.L., Bull, D.A., et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364 (2011), 797–805.
16. 16 Bart, B.A., Goldsmith, S.R., Lee, K.L., et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med 367 (2012), 2296–2304.
17. 17 Chen, H.H., Anstrom, K.J., Givertz, M.M., et al. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA 310 (2013), 2533–2543.
18. 18 Kenchaiah, S., Evans, J.C., Levy, D., et al. Obesity and the risk of heart failure. N Engl J Med 347 (2002), 305–313.
19. 19 Borlaug, B.A., The pathophysiology of heart failure with preserved ejection fraction. Nature Rev Cardiol 11 (2014), 507–515.
20. 20 Mehra, M.R., Uber, P.A., Park, M.H., et al. Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol 43 (2004), 1590–1595.
21. 21 Peacock, W.F. 4th, De Marco, T., Fonarow, G.C., et al. Cardiac troponin and outcome in acute heart failure. N Engl J Med 358 (2008), 2117–2126.
22. 22 Felker, G.M., Hasselblad, V., Tang, W.H., et al. Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study. Eur J Heart Fail 14 (2012), 1257–1264.
23. 23 Kenchaiah, S., Pocock, S.J., Wang, D., et al. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 116 (2007), 627–636.
24. 24 Mehra, M.R., Kobashigawa, J., Starling, R., et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006. J Heart Lung Transplant 25 (2006), 1024–1042.
25. 25 Slaughter, M.S., Pagani, F.D., Rogers, J.G., et al. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant 29 (2010), S1–S39.
26. 26 Turkbey, E.B., McClelland, R.L., Kronmal, R.A., et al. The impact of obesity on the left ventricle: the Multi–Ethnic Study of Atherosclerosis (MESA). J Am Col Cardiol IMG 3 (2010), 266–274.
27. 27 Lavie, C.J., Osman, A.F., Milani, R.V., Mehra, M.R., Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol 91 (2003), 891–894.
28. 28 Clark, A.L., Fonarow, G.C., Horwich, T.B., Waist circumference, body mass index, and survival in systolic heart failure: the obesity paradox revisited. J Card Fail 17 (2011), 374–380.